Abstract:Since the onset of the COVID-19 pandemic, a variety of diagnostic approaches, including RT-qPCR, RAPID, and LFA, have been adopted, with RT-qPCR emerging as the gold standard. However, a significant challenge in COVID-19 diagnostics is the wide range of symptoms presented by patients, necessitating early and accurate diagnosis for effective management. Although RT-qPCR is a precise molecular technique, it is not immune to false-negative results. In contrast, CRISPR-based detection methods for SARS-CoV-2 offer several advantages: they are cost-effective, time-efficient, highly sensitive, and specific, and they do not require sophisticated instruments. These methods also show promise for scalability, enabling diagnostic tests. CRISPR technology can be customized to target any genomic region of interest, making it a versatile tool with applications beyond diagnostics, including therapeutic development. The CRISPR/Cas systems provide precise gene targeting with immense potential for creating next-generation diagnostics and therapeutics. One of the key advantages of CRISPR/Cas-based therapeutics is the ability to perform multiplexing, where different sgRNAs or crRNAs can target multiple sites within the same gene, reducing the likelihood of viral escape mutants. Among the various CRISPR systems, CRISPR/Cas13 and CARVER (Cas13-assisted restriction of viral expression and readout) are particularly promising. These systems can target a broad range of single-stranded RNA viruses, making them suitable for the diagnosis and treatment of various viral diseases, including SARS-CoV-2. However, the efficacy and safety of CRISPR-based therapeutics must be thoroughly evaluated in pre-clinical and clinical settings. While CRISPR biotechnologies have not yet been fully harnessed to control the current COVID-19 pandemic, there is an optimism that the limitations of the CRISPR/Cas system can be overcome soon. This review discusses how CRISPR-based strategies can revolutionize disease diagnosis and therapeutic development, better preparing us for future viral threats.

CRISPR-based strategies in infectious disease diagnosis and therapy

The application of CRISPR genome editing technologies in the pathogenesis studies, diagnosis, prevention and treatment of infectious diseases

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis

The Applications of the CRISPR/Cas9 Gene-Editing System in Treating Human Diseases

CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine

CRISPR/Cas technology as a promising weapon to combat viral infections

Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics

The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications

The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

CRISPR/Cas Technology: The Unique Synthetic Biology Genome-Editing Tool Shifting the Paradigm in Viral Diagnostics, Defense, and Therapeutics

Advances in CRISPR-Cas systems for human bacterial disease

CRISPR-Cas system: from diagnostic tool to potential antiviral treatment

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

CRISPR-Cas System: The Current and Emerging Translational Landscape

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications

Advancements of CRISPR/Cas9 technology and its value in antiviral therapeutics

CRISPR-Cas Systems: Overview, Innovations and Applications in Human Disease Research and Gene Therapy

CRISPR-Cas Systems: Programmable Nuclease Revolutionizing the Molecular Diagnosis